Results
|
41.
|
Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trial. [electronic resource] by
- Barnett, M L
- Kremer, J M
- St Clair, E W
- Clegg, D O
- Furst, D
- Weisman, M
- Fletcher, M J
- Chasan-Taber, S
- Finger, E
- Morales, A
- Le, C H
- Trentham, D E
Producer: 19980319
In:
Arthritis and rheumatism vol. 41
Availability: No items available.
|
|
42.
|
Prospective randomized trial of maintenance immunosuppression with rapid discontinuation of prednisone in adult kidney transplantation. [electronic resource] by
- Suszynski, T M
- Gillingham, K J
- Rizzari, M D
- Dunn, T B
- Payne, W D
- Chinnakotla, S
- Finger, E B
- Sutherland, D E R
- Najarian, J S
- Pruett, T L
- Matas, A J
- Kandaswamy, R
Producer: 20131209
In:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons vol. 13
Availability: No items available.
|
|
43.
|
Ambroxol as a novel disease-modifying treatment for Parkinson's disease dementia: protocol for a single-centre, randomized, double-blind, placebo-controlled trial. [electronic resource] by
- Silveira, C R A
- MacKinley, J
- Coleman, K
- Li, Z
- Finger, E
- Bartha, R
- Morrow, S A
- Wells, J
- Borrie, M
- Tirona, R G
- Rupar, C A
- Zou, G
- Hegele, R A
- Mahuran, D
- MacDonald, P
- Jenkins, M E
- Jog, M
- Pasternak, S H
Producer: 20190313
In:
BMC neurology vol. 19
Availability: No items available.
|
|
44.
|
The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 (6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one) enhances synaptic plasticity and cognitive function in rodents. [electronic resource] by
- Hutson, P H
- Finger, E N
- Magliaro, B C
- Smith, S M
- Converso, A
- Sanderson, P E
- Mullins, D
- Hyde, L A
- Eschle, B K
- Turnbull, Z
- Sloan, H
- Guzzi, M
- Zhang, X
- Wang, A
- Rindgen, D
- Mazzola, R
- Vivian, J A
- Eddins, D
- Uslaner, J M
- Bednar, R
- Gambone, C
- Le-Mair, W
- Marino, M J
- Sachs, N
- Xu, G
- Parmentier-Batteur, S
Producer: 20120525
In:
Neuropharmacology vol. 61
Availability: No items available.
|
|
45.
|
TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers. [electronic resource] by
- Finch, N
- Carrasquillo, M M
- Baker, M
- Rutherford, N J
- Coppola, G
- Dejesus-Hernandez, M
- Crook, R
- Hunter, T
- Ghidoni, R
- Benussi, L
- Crook, J
- Finger, E
- Hantanpaa, K J
- Karydas, A M
- Sengdy, P
- Gonzalez, J
- Seeley, W W
- Johnson, N
- Beach, T G
- Mesulam, M
- Forloni, G
- Kertesz, A
- Knopman, D S
- Uitti, R
- White, C L
- Caselli, R
- Lippa, C
- Bigio, E H
- Wszolek, Z K
- Binetti, G
- Mackenzie, I R
- Miller, B L
- Boeve, B F
- Younkin, S G
- Dickson, D W
- Petersen, R C
- Graff-Radford, N R
- Geschwind, D H
- Rademakers, R
Producer: 20110328
In:
Neurology vol. 76
Availability: No items available.
|